You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pancreatic adenocarcinoma

Showing 1 - 25 of 6,047
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)

Not yet recruiting
  • Pancreas Cancer
  • Pancreas Adenocarcinoma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
Oct 29, 2023

HER-2 Expression in Pancreatic Duct Adenocarcinoma

Completed
  • Pancreatic Adenocarcinoma
  • immunohistochemical approach
  • (no location specified)
Sep 20, 2023

Cancer Of Pancreas Trial (Analyze of GemCore status)

Not yet recruiting
  • Cancer Of Pancreas
  • Analyze of GemCore status
  • (no location specified)
Sep 19, 2023

Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

Not yet recruiting
  • Locally Advanced Unresectable Pancreatic Adenocarcinoma
  • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
  • (no location specified)
Jun 25, 2023

PDAC - Pancreatic Ductal Adenocarcinoma Trial in Verona (ctDNA analysis)

Recruiting
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • ctDNA analysis
  • Verona, Italy
    AOUI Verona
May 8, 2023

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Avelumab and Pepinemab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Avelumab and Pepinemab
  • Rochester, New York
    University of Rochester Medical Center
Jan 19, 2023

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • BNT321 Dose Level 1
  • +3 more
  • (no location specified)
Sep 29, 2023

Pancreatic Adenocarcinoma Trial in Stanford (ExAblate 2100)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • ExAblate 2100
  • Stanford, California
    Stanford Cancer Center
Oct 25, 2022

18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

Completed
  • 18F-FAPI
  • +4 more
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
May 31, 2023

Resected Pancreatic and Ampullary Adenocarcinoma at Favorable

Enrolling by invitation
  • Resectable Pancreatic Adenocarcinoma
    • Milan, Italy
      National Cancer Institute of Milan
    Mar 3, 2023

    Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • Resectable Pancreatic Cancer
    • Nab paclitaxel
    • +2 more
    • (no location specified)
    Dec 5, 2022

    PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

    Not yet recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
    • (no location specified)
    Jul 9, 2023

    Treatment Response in Patients With Pancreatic Adenocarcinoma

    Not yet recruiting
    • Pancreatic Adenocarcinoma
      • Besançon, France
      • +14 more
      Mar 8, 2023

      Locally Advanced Pancreatic Adenocarcinoma Trial in Houston (SD-101, pebrolizumab)

      Recruiting
      • Locally Advanced Pancreatic Adenocarcinoma
      • Houston, Texas
        MD Anderson Cancer Center
      Nov 18, 2022

      Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)

      Not yet recruiting
      • Pancreatic Cancer
      • +2 more
      • DaRT seeds insertion
      • (no location specified)
      Sep 5, 2023

      Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

      Not yet recruiting
      • Advanced Pancreatic Adenocarcinoma
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Aug 23, 2023

      Pancreatic Adenocarcinoma Trial in Baltimore (TraceIT tissue marker injection)

      Completed
      Has Results
      • Pancreatic Adenocarcinoma
      • TraceIT tissue marker injection
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Jan 20, 2023

      Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

      Recruiting
      • Metastatic Pancreatic Ductal Adenocarcinoma
      • +12 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Nov 30, 2022

      Pancreatic Adenocarcinoma Trial in Los Angeles (Pancrelipase)

      Recruiting
      • Pancreatic Adenocarcinoma
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jul 15, 2022

      Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)

      Recruiting
      • Pancreatic Adenocarcinoma
      • Hamilton, Ontario, Canada
        Juravinski Hospital
      Aug 5, 2022

      Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • Homologous Recombination Deficiency
      • (no location specified)
      Oct 18, 2023

      Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

      Completed
      Has Results
      • Pancreatic Adenocarcinoma
      • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
      • +3 more
      • Dallas, Texas
        UT Southwestern Medical Center
      Oct 10, 2022